Results 161 to 170 of about 39,038 (256)

Unintentional periconceptional exposure to glucagon‐like peptide‐1 receptor agonists and adverse pregnancy outcomes: A nationwide cohort study in Taiwan

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1420-1430, February 2026.
Abstract Aims To assess whether periconceptional exposure to glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) is associated with adverse outcomes in women with pregestational type 2 diabetes. Materials and Methods We linked Taiwan's Birth Certificate Application and National Health Insurance claims (2013–2022) to assemble a nationwide cohort of ...
Yi‐Chang Chou, Shih‐Han Weng, Feng‐Shiang Cheng, Chih‐Hao Tseng, Hsiao‐Yun Hu, Chieh‐Hsing Liu   +5 more
wiley   +1 more source

Long-term efficacy and safety of tirzepatide in participants with type 2 diabetes with inadequate glycaemic control on metformin and/or sulfonylurea: Post-hoc analysis of SURPASS-4. [PDF]

Diabetes Obes Metab
Guan H, Jiang H, Yuan H, Sun J, Xu J, Ji L.   +5 more
europepmc   +1 more source

Comparative effectiveness of sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists for incident dementia: A retrospective multicohort study

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1443-1452, February 2026.
Abstract Objective This study provides real‐world evidence on the comparative effectiveness of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) regarding the risk of incident dementia in adults with type 2 diabetes mellitus (T2DM).
Filippos Anagnostakis, Michail Kokkorakis, Shrihari Nagarajan, Georgia Anastasiou, Christos S. Mantzoros   +4 more
wiley   +1 more source

Case Report: When genetic diagnosis comes late: lessons from a DEND syndrome patient successfully transitioned to sulfonylurea. [PDF]

Front Clin Diabetes Healthc
Abreu GM, Bastos de Souza R, Bernardo MC, da Cruz Junior JL, Ferreira A, Snaider D, da Fonseca ACP, Salum KCR, Zembrzuski VM, Lima MA, Tarantino RM, Rodacki M, Zajdenverg L, Luescher JL, Rosado EL, Campos Junior M.   +15 more
europepmc   +1 more source

Safety and effectiveness of tirzepatide during Ramadan fasting: Real‐world evidence from patients with type 2 diabetes in Bangladesh

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1508-1516, February 2026.
Abstract Aims Ramadan fasting poses challenges for patients with type 2 diabetes mellitus (T2DM) due to increased risks of hypoglycemia and metabolic fluctuations. Tirzepatide, a dual GIP/GLP‐1 receptor agonist, has shown marked efficacy in glycemic control and weight reduction.
Muhammad Hafizur Rahman, Shahjada Selim, Faria Afsana, Md. Azizul Hoque, M. Saifuddin, Md. Shah Alam, Mirza Sharifuzzaman, Mohmmad Abdul Hannan, Md. Nazmul Hasan, A. B. M. Kamrul‐Hasan, Marufa Mustari, Afsar Ahammed   +11 more
wiley   +1 more source

Stacked mutations in multi-copy AHAS genes enhance sulfonylurea herbicide resistance in soybean. [PDF]

Plant J
Park K, Kim HJ, Choi Y, Kang M, Shin Y, Lim H, Choi M, Park H, Park S, Jeong D, Chung YS, Kim SG.   +11 more
europepmc   +1 more source

Caring for Australians and New Zealanders with kidney Impairment guidelines commentary on the Kidney Disease: Improving Global Outcomes clinical practice guideline for management of diabetes and chronic kidney disease

Internal Medicine Journal, Volume 56, Issue 2, Page 274-279, February 2026.
Abstract Diabetes is a leading cause of kidney failure, and individuals with both diabetes and chronic kidney disease (CKD) experience significantly higher rates of complications and mortality. The international guideline developer Kidney Disease: Improving Global Outcomes (KDIGO) has produced clinical practice guidelines that reflect recent advances ...
Hannah Wallace, Mia E. Abdy, Kathie Anderson, Effie Johns, Thu Nguyen, Carla Scuderi, Vincent Lee, David J. Tunnicliffe, Min Jun, on behalf CARI Guidelines Steering Committee, Emily See, Leanne Brown, Helen Coolican, Jonathan Craig, Vanessa Cullen, Jeffrey Ha, Rathika Krishnasamy, Kelly Lambert, Casey Light, Emmy O'Neill, Hannah Smith, Andrea Viecelli   +21 more
wiley   +1 more source

Blood Pressure Status Modulates the Therapeutic Response to Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Macular Edema: A Post Hoc Subgroup Analysis of the COMET Trial. [PDF]

J Diabetes
Ishibashi R, Koshizaka M, Takatsuna Y, Tatsumi T, Baba T, Yamamoto S, Yokote K.   +6 more
europepmc   +1 more source

Sulfonylurea [PDF]

, 2020
openaire   +1 more source

The sulfonylurea receptor

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1992
Ashcroft, S, Ashcroft, F
openaire   +2 more sources